These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 18566484)
1. Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans. Abraham VC; Towne DL; Waring JF; Warrior U; Burns DJ J Biomol Screen; 2008 Jul; 13(6):527-37. PubMed ID: 18566484 [TBL] [Abstract][Full Text] [Related]
2. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496 [TBL] [Abstract][Full Text] [Related]
3. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Tolosa L; Pinto S; Donato MT; Lahoz A; Castell JV; O'Connor JE; Gómez-Lechón MJ Toxicol Sci; 2012 May; 127(1):187-98. PubMed ID: 22331495 [TBL] [Abstract][Full Text] [Related]
4. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329 [TBL] [Abstract][Full Text] [Related]
5. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes. Aly HA; Domènech O Toxicology; 2009 Aug; 262(3):175-83. PubMed ID: 19486918 [TBL] [Abstract][Full Text] [Related]
6. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells. Atienzar F; Gerets H; Dufrane S; Tilmant K; Cornet M; Dhalluin S; Ruty B; Rose G; Canning M Toxicol Sci; 2007 Mar; 96(1):101-14. PubMed ID: 17175557 [TBL] [Abstract][Full Text] [Related]
7. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved. Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584 [TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput human HepG(2) dual luciferase assay for detection of metabolically activated hepatotoxicants and genotoxicants. Liu X; Kramer JA; Hu Y; Schmidt JM; Jiang J; Wilson AG Int J Toxicol; 2009; 28(3):162-76. PubMed ID: 19546255 [TBL] [Abstract][Full Text] [Related]
9. Validation of a high-throughput in vitro alkaline elution/rat hepatocyte assay for DNA damage. Gealy R; Wright-Bourque JL; Kraynak AR; McKelvey TW; Barnum JE; Storer RD Mutat Res; 2007 Apr; 629(1):49-63. PubMed ID: 17306613 [TBL] [Abstract][Full Text] [Related]
10. The combined use of human neural and liver cell lines and mouse hepatocytes improves the predictability of the neurotoxicity of selected drugs. Mannerström M; Toimela T; Ylikomi T; Tähti H Toxicol Lett; 2006 Aug; 165(2):195-202. PubMed ID: 16701969 [TBL] [Abstract][Full Text] [Related]
11. Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. Gerets HH; Hanon E; Cornet M; Dhalluin S; Depelchin O; Canning M; Atienzar FA Toxicol In Vitro; 2009 Mar; 23(2):319-32. PubMed ID: 19110050 [TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
13. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619 [TBL] [Abstract][Full Text] [Related]
14. Early safety assessment using cellular systems biology yields insights into mechanisms of action. Giuliano KA; Gough AH; Taylor DL; Vernetti LA; Johnston PA J Biomol Screen; 2010 Aug; 15(7):783-97. PubMed ID: 20639501 [TBL] [Abstract][Full Text] [Related]
15. In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates. Olaharski AJ; Uppal H; Cooper M; Platz S; Zabka TS; Kolaja KL Toxicol Lett; 2009 Jul; 188(2):98-103. PubMed ID: 19446241 [TBL] [Abstract][Full Text] [Related]
16. Comparative sensitivity of tumor and non-tumor cell lines as a reliable approach for in vitro cytotoxicity screening of lysine-based surfactants with potential pharmaceutical applications. Nogueira DR; Mitjans M; Infante MR; Vinardell MP Int J Pharm; 2011 Nov; 420(1):51-8. PubMed ID: 21871545 [TBL] [Abstract][Full Text] [Related]
17. High throughput, non-invasive and dynamic toxicity screening on adherent cells using respiratory measurements. Beckers S; Noor F; Müller-Vieira U; Mayer M; Strigun A; Heinzle E Toxicol In Vitro; 2010 Mar; 24(2):686-94. PubMed ID: 19427895 [TBL] [Abstract][Full Text] [Related]
19. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Tornier C; Rosdy M; Maibach HI Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985 [TBL] [Abstract][Full Text] [Related]
20. Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Rich IN; Hall KM Toxicol Sci; 2005 Oct; 87(2):427-41. PubMed ID: 16002476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]